# Availability of essential cancer medicines in Botswana's public sector, 2015

Source: https://onco.cc/key-papers/paper-martei-essential-cancer-medicines-botswana-jgo-2018/  
OnCo record `paper-martei-essential-cancer-medicines-botswana-jgo-2018` (Key paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Botswana's 2015 national list of essential cancer medicines matched four fifths of the World Health Organization's list. Even so, at least 40% of the essential cancer drugs were out of stock for a median of 30 days during that year.

## Summary

Published as "Availability of WHO Essential Medicines for Cancer Treatment in Botswana". The authors analysed the weekly stock catalogue that the government's Central Medical Store sends to pharmacy departments in government hospitals, compared prices with an international price guide, and interviewed key informants about the national essential medicines list and the public supply chain.

## Fields

- Kind: Key paper
- Last checked: 2026-11-16
- Journal: Journal of Global Oncology
- Year: 2018
- DOI: 10.1200/jgo.17.00063
- Authors: Martei YM, Chiyapo S, Grover S, et al.
- Findings: The 2015 national essential medicines list for cancer had 80.5% alignment with WHO's list.; At least 40% of essential cancer drugs were out of stock for a median of 30 days in 2015.; Stock-outs affected chemotherapy in first-line regimens for cervical, breast and colorectal cancer and were not associated with the price of the drug.; The median price ratio was above 1 for 61% of the listed drugs, which the authors read as inefficient procurement.
- What it means: Having a medicine on the national list did not guarantee it was on the shelf. The authors propose using cancer registry data and treatment guidelines to forecast how much chemotherapy is needed.
- Caveats: Data are for 2015 and the public sector only.; The study measured stock at the central store, not what individual patients received.

## Sources

- Journal of Global Oncology 2018: https://doi.org/10.1200/jgo.17.00063
- PubMed: https://pubmed.ncbi.nlm.nih.gov/30241225/

## Connected records

- key papers: [Cancer incidence in people with and without HIV in Botswana, 1990 to 2021](https://onco.cc/key-papers/paper-mathoma-cancer-incidence-hiv-botswana-cancers-2025/), [Services at Botswana's four public oncology centres, surveyed in 2021](https://onco.cc/key-papers/paper-swart-public-oncology-centres-botswana-jcogo-2024/)
- technologies: [Global oncology and access in low- and middle-income countries](https://onco.cc/technologies/global-oncology-access/)
- institutions: [Botswana National Cancer Registry (BNCR)](https://onco.cc/institutions/botswana-national-cancer-registry/), [Ministry of Health, Botswana](https://onco.cc/institutions/botswana-ministry-of-health/)

---
JSON: https://onco.cc/api/v1/entities/paper-martei-essential-cancer-medicines-botswana-jgo-2018.json